| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| ATLCAR.CD138 (UNC Lineberger Comprehensive Cancer Center) | Phase 1 Clinical | Unc Lineberger Comprehensive Cancer Center | Immune System Diseases; Multiple Myeloma | Details | |
| QXL-138AM | QXL-138AM | Phase 1 Clinical | Nammi Therapeutics Inc | Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Gastrointestinal Neoplasms; Lung Neoplasms; Multiple Myeloma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Solid tumours | Details |